Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people recently diagnosed with cancer ("cases"):
- You have been newly diagnosed with cancer within the last 120 days, or have had a cancer come back after being cancer-free for more than 5 years, and your cancer is one of these types: Brain, Breast, Bladder, Cervical, Colorectal, Endometrial, Esophageal, Stomach, Head and Neck, Liver/Bile Duct, Lung, Ovarian, Pancreatic, Prostate, Kidney, Sarcoma, Thyroid, Leukemia, Lymphoma, or Multiple Myeloma.
- You are able and willing to give your consent to take part in the study.
- You are 40 years of age or older.
For people without a recent cancer diagnosis ("controls"):
- You have not been diagnosed with any invasive cancer in the last 5 years (a history of non-invasive cancer is allowed).
- You are able and willing to give your consent to take part in the study.
- You are 40 years of age or older.
Who may not be able to join:
For people recently diagnosed with cancer ("cases"):
- You are currently receiving any treatment for cancer.
- You are currently taking medications known as demethylating agents or DNA hypomethylating agents (confirm with trial site).
- You have been diagnosed with two or more invasive cancers at the same time.
- You have been diagnosed with any other invasive or non-invasive cancer in the last 5 years, in addition to your current cancer.
- You currently have a long-term blood cancer (such as chronic CLL) in addition to your current cancer.
- You currently have a bone marrow condition such as myelodysplastic syndrome, or a precursor blood condition such as MGUS, in addition to your current cancer (confirm with trial site).
- You are pregnant (based on self-report).
For people without a recent cancer diagnosis ("controls"):
- You are currently receiving any treatment for cancer.
- You are currently taking medications known as demethylating agents or DNA hypomethylating agents (confirm with trial site).
- You are pregnant (based on self-report).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brian Rini, MD, Vanderbilt-Ingram Cancer Center
Phone: 203-514-4155
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.